This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 May;14(2):48.

doi: 10.1136/ebmh.14.2.48.

Review: reboxetine is ineffective and potentially harmful for acute treatment of major depression

Martin A Katzman¹, Dina Tsirgielis

Affiliations

PMID: 21502154
DOI: 10.1136/ebmh.14.2.48

Comment

Review: reboxetine is ineffective and potentially harmful for acute treatment of major depression

Martin A Katzman et al. Evid Based Ment Health. 2011 May.

. 2011 May;14(2):48.

doi: 10.1136/ebmh.14.2.48.

Authors

Martin A Katzman¹, Dina Tsirgielis

Affiliation

¹ START Clinic for Mood and Anxiety Disorders, Toronto, Ontario, Canada.

PMID: 21502154
DOI: 10.1136/ebmh.14.2.48

No abstract available

PubMed Disclaimer

Comment on

Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials.
Eyding D, Lelgemann M, Grouven U, Härter M, Kromp M, Kaiser T, Kerekes MF, Gerken M, Wieseler B. Eyding D, et al. BMJ. 2010 Oct 12;341:c4737. doi: 10.1136/bmj.c4737. BMJ. 2010. PMID: 20940209 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.